• 1. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 2. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 3. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 4. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 5. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzyloxycarbonyls

Recent Advances in the Application of 1-Benzyloxycarbonylpyrrolidine-3-carboxylic Acid (CAS: 188527-21-1) in Chemical Biology and Pharmaceutical Research

The compound 1-benzyloxycarbonylpyrrolidine-3-carboxylic acid (CAS: 188527-21-1) has recently garnered significant attention in chemical biology and pharmaceutical research due to its versatile applications as a key intermediate in drug synthesis and its potential role in modulating biological pathways. This research briefing synthesizes the latest findings on this compound, highlighting its chemical properties, synthetic utility, and emerging therapeutic applications.

Recent studies have demonstrated the efficacy of 1-benzyloxycarbonylpyrrolidine-3-carboxylic acid as a building block for the synthesis of novel protease inhibitors. A 2023 study published in the Journal of Medicinal Chemistry utilized this compound to develop a series of covalent inhibitors targeting SARS-CoV-2 main protease (Mpro), showing promising antiviral activity with IC50 values in the low micromolar range. The benzyloxycarbonyl (Cbz) protecting group was found to be particularly advantageous for subsequent deprotection steps in the synthetic pathway.

In the field of peptide mimetics, researchers have exploited the constrained conformation of the pyrrolidine ring in 188527-21-1 to design potent and selective agonists for G protein-coupled receptors (GPCRs). A notable application appears in recent work on melanocortin receptor modulators, where derivatives of this compound exhibited improved metabolic stability compared to linear peptides while maintaining high receptor binding affinity (Bioorganic & Medicinal Chemistry Letters, 2024).

The compound's potential in central nervous system drug development has been explored through its incorporation into γ-aminobutyric acid (GABA) analogs. Structural modifications at the 3-carboxylic acid position have yielded compounds with enhanced blood-brain barrier permeability and prolonged duration of action in animal models of epilepsy and neuropathic pain (European Journal of Pharmacology, 2023). These findings suggest that 1-benzyloxycarbonylpyrrolidine-3-carboxylic acid serves as a valuable scaffold for CNS-active drug candidates.

From a synthetic chemistry perspective, recent methodological advances have improved the efficiency of producing 188527-21-1 and its derivatives. A 2024 report in Organic Process Research & Development described a continuous flow chemistry approach that reduced reaction times from hours to minutes while achieving >95% purity. This technological innovation addresses previous challenges in scaling up production of this important intermediate.

Emerging applications in targeted drug delivery systems have utilized 1-benzyloxycarbonylpyrrolidine-3-carboxylic acid as a linker molecule in antibody-drug conjugates (ADCs). Its stability in circulation and selective cleavage characteristics under specific physiological conditions make it particularly suitable for this application, as demonstrated in recent preclinical studies of HER2-targeted anticancer agents (Molecular Pharmaceutics, 2024).

In conclusion, 1-benzyloxycarbonylpyrrolidine-3-carboxylic acid (188527-21-1) continues to demonstrate remarkable versatility across multiple areas of pharmaceutical research. Its applications span from serving as a fundamental building block in medicinal chemistry to enabling advanced drug delivery technologies. The compound's unique structural features and synthetic flexibility position it as an increasingly important tool in the development of next-generation therapeutics. Future research directions may explore its potential in PROTAC design and other emerging modalities in chemical biology.

• 1142-20-7(N-[(Benzyloxy)carbonyl]-L-alanine)
• 1155-64-2(H-Lys(Z)-OH)
• 276872-86-7(Benzyl 3-formylpyrrolidine-1-carboxylate)
• 10314-98-4(1-benzyloxycarbonylpiperidine-4-carboxylic acid)
• 1138-80-3(Z-Glycine)
• 1148-11-4(Carbobenzoxyproline)
• 405-39-0(Z-Lys(Z)-OH)
• 1152-61-0(Z-Asp-OH)
• 1155-62-0(N-Carbobenzoxy-L-glutamic acid)
• 1149-26-4(N-Cbz-L-valine)